Science – Talk Bio

Amgen to Invest Over $600M in New Innovation Centre at California Headquarters

2 weeks ago talkbio0Tagged amgen, Automation, Biotechnology, California, Capital, Construction worker, digital tools, ELAVL2 gene, Incentives, innovation, innovation centre, Investments, Science, therapeutic development, Thousand Oaks

Amgen; innovation centre; science and innovation hub; Thousand Oaks; California; biotechnology; construction; automation; digital tools; therapeutic development; tax incentives; capital investment

Exact Sciences plans ‘transformative year’ with 3 cancer test debuts

5 months ago talkbio0Tagged Exact brand biomedical or dental material, Hypersensitivity, MRD, Science

Science, MRD, Exact brand biomedical or dental material, Hypersensitivity

Thermo Fisher jumps on the US investment bandwagon with $2B in additional spending

5 months ago talkbio0Tagged development aspects, Investments, Manufacture, Martes pennanti, Science, Thermo Fisher, United States

United States, Investments, Manufacture, Martes pennanti, Science, development aspects, Thermo Fisher

NIHs funding cut plan poses challenges for researchers despite court halt

7 months ago talkbio0Tagged Impact food supplement, Indirect, Legal, NIH Mouse, Research Projects, R-Series, Science

NIH funding cuts, indirect costs, research grants, legal challenges, scientific community impact

Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology

9 months ago talkbio0Tagged Aortic Valve Insufficiency, biotech, Capital, Dimensions, innovation, Machine Learning, Science, Technology, venture

Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation

Lil Jon Teams Up with Singing Toilet for Unconventional Cancer Awareness Campaign

10 months ago talkbio0Tagged cancer kit, Coprophilia (disorder), Lil Jon, promotional campaign, Science, Singing, Toilet procedure

Lil Jon, scat rap, singing toilet, Exact Sciences, cancer kit, promotional campaign

Kinevant Sciences Discontinues Namilumab Development for Pulmonary Sarcoidosis Following Phase 2 Failure

10 months ago talkbio0Tagged Anti-GM-CSF, Kinevant, Monoclonal Antibodies, namilumab, Phase 2 Clinical Trials, Sarcoidosis, Pulmonary, Science

Namilumab, Pulmonary Sarcoidosis, Phase 2 Study, Kinevant Sciences, RESOLVE-Lung Study, Anti-GM-CSF Monoclonal Antibody

Historic Settlement: Lacks Family Reaches Agreement with Thermo Fisher Scientific Over Unjust Enrichment from HeLa Cells

11 months ago talkbio0Tagged Biotechnology, Consent, HeLa Cells, Henrietta Lacks, racial injustice, Science, settlement, Thermo Fisher

Henrietta Lacks, HeLa cells, Thermo Fisher Scientific, unjust enrichment, racial injustice, medical ethics, consent, biotechnology, settlement.

KdT Ventures Secures $100M Fourth Fund to Fuel Early-Stage Biotech Startups

11 months ago talkbio0Tagged Early-stage, frontier, Investments, KdT, Science, startups, Ventures

KdT Ventures, $100M fund, early-stage startups, biotech, frontier science, life sciences investment

Cereno’s CS1 Shows Promising Results in Reducing PAH Risks in Phase 2 Trial

12 months ago talkbio0Tagged Cereno, disease-modifying, Epigenetic modulation, HDAC9 gene, Inhibitor, Phase 2 trial, Pulmonary arterial hypertension, Science, SLAMF7 protein, human

Cereno Scientific, CS1, HDAC inhibitor, Pulmonary Arterial Hypertension (PAH), Phase 2 trial, Epigenetic modulation, CardioMEMS HF System, Disease-modifying treatment